Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026)
Avantor (AVTR) recorded quarterly Liabilities and Shareholders Equity of $11.7 billion in Q1 2026, down 1.12% quarter-over-quarter from $11.8 billion in Q4 2025, and down 5.38% on a YoY basis from $12.3 billion in Q1 2025.
Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Avantor's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $11.7 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 5.38% year-over-year to $11.7 billion; the TTM figure through Mar 2026 stood at $47.9 billion (down 4.13% YoY), while the FY2025 annual figure was $11.8 billion, down 2.64% from the prior year.
- Liabilities and Shareholders Equity was $11.7 billion for Q1 2026 at Avantor, down from $11.8 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $13.8 billion in Q1 2022 to a low of $5.3 billion in Q4 2022.
- Historically, Liabilities and Shareholders Equity has averaged $11.9 billion across 5 years, with a median of $12.8 billion in 2024.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity jumped 103.38% in 2024, then dropped 9.07% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $5.3 billion in 2022, then climbed by 13.4% to $6.0 billion in 2023, then surged by 103.38% to $12.1 billion in 2024, then slipped by 2.64% to $11.8 billion in 2025, then retreated by 1.12% to $11.7 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $11.7 billion (Q1 2026), $11.8 billion (Q4 2025), and $11.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 151.46 Bn | 147.07 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 43.06 Bn | 42.04 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 29.49 Bn | 35.33 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.58 Bn | 26.92 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 24.11 Bn | 23.59 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 14.37 Bn | 14.37 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.38 Bn | 13.25 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.32 Bn | 8.27 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Avantor | 6.71 Bn | 6.43 Bn | 500.70 Mn | 11.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.66 Bn |
| Dec 31, 2025 | 11.79 Bn |
| Sep 30, 2025 | 11.68 Bn |
| Jun 30, 2025 | 12.78 Bn |
| Mar 31, 2025 | 12.33 Bn |
| Dec 31, 2024 | 12.11 Bn |
| Sep 30, 2024 | 12.84 Bn |
| Jun 30, 2024 | 12.69 Bn |
| Mar 31, 2024 | 12.76 Bn |
| Dec 31, 2023 | 5.96 Bn |
| Sep 30, 2023 | 12.80 Bn |
| Jun 30, 2023 | 13.06 Bn |
| Mar 31, 2023 | 13.40 Bn |
| Dec 31, 2022 | 5.25 Bn |
| Sep 30, 2022 | 13.11 Bn |
| Jun 30, 2022 | 13.43 Bn |
| Mar 31, 2022 | 13.84 Bn |
| Dec 31, 2021 | 4.86 Bn |
| Sep 30, 2021 | 12.20 Bn |
| Jun 30, 2021 | 11.25 Bn |